Results 201 to 210 of about 322,522 (245)

Phenolic Profile and Bioactive Prospects of Wild Annona Species From Angola

Chemistry &Biodiversity, EarlyView.
ABSTRACT Annona species (Annonaceae family) are valued for their nutritional and medicinal importance, especially in traditional medicine. This study investigated the phenolic profiles of the Angolan Annona muricata, Annona squamosa, and Annona senegalensis leaves, stem barks, and seeds hydroethanolic, infusion, and decoction extracts, also evaluating ...
Josefa Rangel, Ângela Liberal, Tiane C. Finimundy, Tânia S. P. Pires, Pedro Cravo, Maria Conceição Silva, Gustavo Capatti Cassiano, Lillian Barros, Maria M. Romeiras, Ângela Fernandes   +9 more
wiley   +1 more source

Correction to: Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders. [PDF]

J Clin Immunol
Palacios-Ortega M, Guerra-Galán T, Jiménez-Huete A, García-Aznar JM, Pérez-Guzmán M, Mansilla-Ruiz MD, Mendiola ÁV, López CP, Hornero EM, Rodriguez AP, Cortijo AP, Zarzuela MP, Morales MM, Mandly EA, Cárdenas MC, Carrero A, García CJ, Bolaños E, Íñigo B, Medina F, de la Fuente E, Ochoa-Grullón J, García-Solís B, García-Carmona Y, Fernández-Arquero M, Benavente-Cuesta C, de Diego RP, Rider N, Sánchez-Ramón S.   +28 more
europepmc   +1 more source

A new case of congenital ficolin-3 deficiency with primary immunodeficiency

, 2020
Fateme Babaha, Hassan Abolhassani, Zahra Hamidi Esfahani, Reza Yazdani, Asghar Aghamohammadi   +4 more
openalex   +2 more sources

Advantages of Exome Sequencing Over Panel Testing for Individuals With a Seizure Indication

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Objective Our aim was to investigate the advantages of exome sequencing versus panel testing for patients with unexplained seizures. Methods We reviewed the diagnostic outcomes of exome sequencing by a commercial genetics laboratory for more than 16 000 individuals with a clinical history of seizures or suspected seizures.
Michelle M. Morrow, Elizabeth Butler, Melanie P. Napier, Lindsay Havens‐Dyer, Annabelle Tuttle, Patricia C. Lopes, Britt A. Johnson, Paul Kruszka, Kirsty McWalter   +8 more
wiley   +1 more source

Diagnostic tests for primary immunodeficiency disorders: Classic and genetic testing. [PDF]

Allergy Asthma Proc
Klangkalya N, Fleisher TA, Rosenzweig SD.   +2 more
europepmc   +1 more source

Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two‐treatment‐period, drug‐drug interaction study evaluated the effect of steady‐state asciminib on the pharmacokinetics of atorvastatin.
Matthias Hoch, Wendy Weis, Felix Huth, Seshulatha Jamalapuram, Michelle Quinlan, Amarnath Bandaru, Suleyman Eralp Bellibas, Asmae Mirkou, Shruti Kapoor, Shefali Kakar   +9 more
wiley   +1 more source

Nanoparticles in microdroplets: Recent advances in microfluidic generators for producing functional microbeads

Droplet, EarlyView.
Functional hybrid microbeads with electrical, magnetic, and/or optical responsiveness have emerged as versatile platforms for biotechnology. This review highlights recent advances in microfluidic technologies for producing such microbeads, with a focus on incorporating functional nanoparticles in microdroplet systems.
  Bayinqiaoge, Chengchen Zhang, Shi‐Yang Tang   +2 more
wiley   +1 more source

Primary Immunodeficiency and Related Diseases

Allergology International, 2012
Hirohisa Saito
doaj   +1 more source

Neurodevelopmental origins of structural and psychomotor defects in CXCR4-linked primary immunodeficiency.

Neuron
Demenego G, Mancinelli S, Borreca A, Proce RO, Aragona V, Miotto M, Cremonesi M, Zucchelli L, Corradini I, Kim E, Ilic K, Fraviga E, Pellegrino L, Badolato R, Rusconi R, Pozzi D, Kallikourdis M, Cash D, Matteoli M, Lodato S.   +19 more
europepmc   +1 more source